These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12929281)

  • 21. [Intravenous morphine titration].
    Aubrun F;
    Ann Fr Anesth Reanim; 2009 Jan; 28(1):e33-7. PubMed ID: 19144492
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety of EMBEda (morphine sulfate and naltrexone hydrochloride) extended-release capsules: review of postmarketing adverse events during the first year.
    Badalamenti VC; Buckley JW; Smith ET
    J Opioid Manag; 2012; 8(2):115-25. PubMed ID: 22616317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arymo ER--a new abuse-deterrent morphine formulation.
    Med Lett Drugs Ther; 2017 Apr; 59(1519):68-69. PubMed ID: 28419074
    [No Abstract]   [Full Text] [Related]  

  • 25. [Morphine].
    Mignat C
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1473-4. PubMed ID: 8983898
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.
    Gibofsky A; Barkin RL
    Am J Ther; 2008; 15(3):241-55. PubMed ID: 18496262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term rectal administration of high-dose sustained-release morphine tablets.
    Walsh D; Tropiano PS
    Support Care Cancer; 2002 Nov; 10(8):653-5. PubMed ID: 12436225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.
    Caldwell JR; Rapoport RJ; Davis JC; Offenberg HL; Marker HW; Roth SH; Yuan W; Eliot L; Babul N; Lynch PM
    J Pain Symptom Manage; 2002 Apr; 23(4):278-91. PubMed ID: 11997197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculating the cost for drug treatment including the adverse drug reactions treatment cost (primer for fentanyl TTS in Bulgaria).
    Petrova GI; Getov IN
    Boll Chim Farm; 2002; 141(2):150-3. PubMed ID: 12135164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 32. [Which hurdles in general practice actually prevent improved pain management? Experiences of a general practitioner with pain patients. Interview by Dr. rer. nat. Anita Schweiger].
    Engl F
    Fortschr Med; 1996 May; 114(13):16-8. PubMed ID: 8964558
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-dose extended-release epidural morphine for pain following hip arthroplasty.
    Viscusi ER; Kopacz D; Hartrick C; Martin G; Manvelian G
    Am J Ther; 2006; 13(5):423-31. PubMed ID: 16988538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer inpatients morphine usage: a New England survey.
    Woollard L
    Aust J Rural Health; 2004 Jun; 12(3):126; author reply 127. PubMed ID: 15200524
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does morphine have a life-shortening effect?].
    Baust G
    MMW Fortschr Med; 2008 Jan; 149 Suppl 4():144-7. PubMed ID: 18402238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Emergency pain treatment--ambulatory intravenous morphine titration in a patient with cancer pain].
    Elsner F; Sabatowski R; Radbruch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Jul; 35(7):462-4. PubMed ID: 10949686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral oxymorphone (Opana).
    Med Lett Drugs Ther; 2007 Jan; 49(1251):3-4. PubMed ID: 17179898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.